Xingda International Holdings Limited - 1899.HK

1899.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1899.HK	-1.4	0.7	2.8	12.4	12.4	-8.2	-17.1	-34.7	-42	-58.8
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 1899.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1899.HK
name	Xingda International Holdings Limited
price	1.45
changes percentage	-1.3605
change	-0.02
day low	1.44
day high	1.46
year high	1.7
year low	1.25
market cap	2760843983
price avg 50	1.3636
price avg 200	1.36195
exchange	HKSE
volume	93000
avg volume	1019602
open	1.46
previous close	1.47
eps	0.27
pe	5.37
earnings announcement	2025-03-24T10:59:00.000+0000
shares outstanding	1904030333
timestamp	2025-01-21 03:45:14

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 66.3%

Overall Quarterly Financial Health: 51.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	11490471000	10812028000	6.27
gross profit	2292125000	2344892000	-2.25
gross profit ratio	0.2	0.22	-8.02
research and development expenses	170719000	169231000	0.88
operating expenses	1450030000	1514149999	-4.23
interest income	52193000	86104000	-39.38
interest expense	233527000	195764000	19.29
ebitda	1611681000	1188533000	35.60
ebitdaratio	0.14	0.11	27.60
operating income	842095000	626068000	34.51
operating income ratio	0.07	0.06	26.56
net income	449401000	348391000	28.99
net income ratio	0.04	0.03	21.38
eps	0.27	0.21	28.57

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 11,490 million in 2023 from 10,812 million in 2022 representing a change of 6.27%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 171 million in 2023 from 169 million in 2022 representing a change of 0.88%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 1,450 million in 2023 from 1,514 million in 2022 representing a change of -4.23%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,612 million in 2023 from 1,189 million in 2022 representing a change of 35.6%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 842 million in 2023 from 626 million in 2022 representing a change of 34.51%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 449 million in 2023 from 348 million in 2022 representing a change of 28.99%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.27 in 2023 from 0.27 in 2022 representing a change of 28.57%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 2,292 million in 2023 from 2,345 million in 2022 representing a change of -2.25%. This indicates a sales profitability decline, which is a negative sign for the company.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	6165692000	6072391000	1.54
gross profit	1208715000	1173225000	3.02
gross profit ratio	0.2	0.19	1.47
research and development expenses	154098000	79525000	93.77
operating expenses	871255000	764698000	13.93
interest income	0	100823000	-100.00
interest expense	0	0	NaN
ebitda	717465000	696807000	2.96
ebitdaratio	0.12	0.11	1.41
operating income	337460000	408527000	-17.40
operating income ratio	0.05	0.07	-18.65
net income	192159000	257358999	-25.33
net income ratio	0.03	0.04	-26.46
eps	0.1	0.15	-33.33

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 6,166 million in 2024Q2 from 6,072 million in 2023Q4 representing a change of 1.54%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,209 million in 2024Q2 from 1,173 million in 2023Q4 representing a change of 3.02%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 717 million in 2024Q2 from 697 million in 2023Q4 representing a change of 2.96%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 154 million in 2024Q2 from 80 million in 2023Q4 representing a change of 93.77%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 871 million in 2024Q2 from 765 million in 2023Q4 representing a change of 13.93%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 337 million in 2024Q2 from 409 million in 2023Q4 representing a change of -17.4%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 192 million in 2024Q2 from 257 million in 2023Q4 representing a change of -25.33%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.1 in 2024Q2 from 0.1 in 2023Q4 representing a change of -33.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	20719862000	21009978000	-1.38
total liabilities	12420971000	13086195000	-5.08
total equity	8298891000	7923782999	4.73
cash and cash equivalents	570801000	824867000	-30.80
short term investments	1864737000	228483000	716.14
long term investments	52645000	709285000	-92.58
total current assets	11587829000	11643994000	-0.48
total non current assets	9132033000	8177693000	11.67
total current liabilities	11568191000	11624168000	-0.48
total non current liabilities	852780000	1152500000	-26.01
common stock	163218000	163218000	0.00
retained earnings	5671763000	5445114000	4.16
total debt	6630829000	6892861000	-3.80

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 20,720 million in 2023 from 21,010 million in 2022 representing a change of -1.38%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 571 million in 2023 from 825 million in 2022 representing a change of -30.8%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 11,588 million in 2023 from 11,644 million in 2022 representing a change of -0.48%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 12,421 million in 2023 from 13,086 million in 2022 representing a change of -5.08%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 8,299 million in 2023 from 7,924 million in 2022 representing a change of 4.73%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 1,865 million in 2023 from 228 million in 2022 representing a change of 716.14%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 11,568 million in 2023 from 11,624 million in 2022 representing a change of -0.48%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 5,672 million in 2023 from 5,445 million in 2022 representing a change of 4.16%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 6,631 million in 2023 from 6,893 million in 2022 representing a change of -3.8%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	22310256000	20719862000	7.68
total liabilities	13773318000	12420971000	10.89
total equity	8536938000	8298891000	2.87
cash and cash equivalents	1095605000	570801000	91.94
short term investments	1258584000	1864737000	-32.51
long term investments	1336548000	725337000	84.27
total current assets	12215042000	11587829000	5.41
total non current assets	10095214000	9132033000	10.55
total current liabilities	11749307000	11568191000	1.57
total non current liabilities	2024011000	852780000	137.34
common stock	186603000	163218000	14.33
retained earnings	5637715000	4633696000	21.67
total debt	7266196000	6630829000	9.58

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 22,310 million in 2024Q2 from 20,720 million in 2023Q4 representing a change of 7.68%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 8,537 million in 2024Q2 from 8,299 million in 2023Q4 representing a change of 2.87%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,096 million in 2024Q2 from 571 million in 2023Q4 representing a change of 91.94%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 12,215 million in 2024Q2 from 11,588 million in 2023Q4 representing a change of 5.41%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 187 in 2024Q2 from 163 in 2023Q4 representing a change of 14.33%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 5,638 million in 2024Q2 from 4,634 million in 2023Q4 representing a change of 21.67%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 13,773 million in 2024Q2 from 12,421 million in 2023Q4 representing a change of 10.89%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 1,259 million in 2024Q2 from 1,865 million in 2023Q4 representing a change of -32.51%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 11,749 million in 2024Q2 from 11,568 million in 2023Q4 representing a change of 1.57%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 7,266 million in 2024Q2 from 6,631 million in 2023Q4 representing a change of 9.58%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-254066000	112502000	-325.83
operating cash flow	1633409000	1580946000	3.32
free cash flow	407954000	-225355000	281.03
capital expenditure	-1225455000	-1806301000	32.16
depreciation and amortization	642403000	578054000	11.13
deferred income tax	0	-109165000	100.00
stock based compensation	2591000	6716000	-61.42
accounts payables	0	-3000000	100.00
inventory	277526000	174226000	59.29
acquisitions net	0	227721000	-100.00
investments in property plant and equipment	-1224373000	-1806301000	32.22
net cash used for investing activites	-941920000	-1801926000	47.73
debt repayment	-307506000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-9167000	-9583000	4.34
dividends paid	-222752000	-203882000	-9.26
net cash used provided by financing activities	-956828000	306386000	-412.29
cash at end of period	570801000	824867000	-30.80
accounts receivables	-64965999	-71777000	9.49
cash at beginning of period	824867000	712365000	15.79

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -254 million in 2023 from 113 million in 2022 representing a change of -325.83%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -1,225 million in 2023 from -1,806 million in 2022 representing a change of 32.16%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -109 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to -65 in 2023 from -72 million in 2022 representing a change of 9.49%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -223 million in 2023 from -204 million in 2022 representing a change of -9.26%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 1,633 million in 2023 from 1,581 million in 2022 representing a change of 3.32%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 408 million in 2023 from -225 million in 2022 representing a change of 281.03%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 3 million in 2023 from 7 million in 2022 representing a change of -61.42%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 3 million in 2022 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	371683000	309049000	20.27
free cash flow	-233597000	-290002000	19.45
capital expenditure	-605280000	-599051000	-1.04
depreciation and amortization	391083000	299032000	30.78
deferred income tax	0	0	NaN
stock based compensation	93000	-205000	145.37
accounts receivables	0	-64965999	100.00
accounts payables	0	0	NaN
inventory	0	277526000	-100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-605280000	-599051000	-1.04
net cash used for investing activites	-402288000	-241454000	-66.61
debt repayment	721125000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	-9167000	100.00
dividends paid	-368208000	-55648000	-561.67
net cash used provided by financing activities	557919000	-654251000	185.28
net change in cash	1095605000	0	NaN
cash at end of period	1095605000	1165193000	-5.97
cash at beginning of period	0	1165193000	-100.00

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,096 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 372 million in 2024Q2 from 309 million in 2023Q4 representing a change of 20.27%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -234 million in 2024Q2 from -290 million in 2023Q4 representing a change of 19.45%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -605 million in 2024Q2 from -599 million in 2023Q4 representing a change of -1.04%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2024Q2 from 0 million in 2023Q4 representing a change of 145.37%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -65 million in 2023Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -368 million in 2024Q2 from -56 million in 2023Q4 representing a change of -561.67%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	6.88	6.52	5.53
net income per share	0.27	0.21	28.09
operating cash flow per share	0.98	0.95	2.59
free cash flow per share	0.24	-0.14	279.76
cash per share	1.46	0.63	129.60
book value per share	4.97	4.77	4.00
tangible book value per share	4.97	-0.08	6426.36
shareholders equity per share	3.65	3.53	3.37
interest debt per share	4.11	4.27	-3.84
market cap	2226059135.22	2300621647.99	-3.24
enterprise value	8286087135.22	8368615647.99	-0.99
pe ratio	4.95	6.6	-24.99
price to sales ratio	0.19	0.21	-8.95
pocfratio	1.36	1.46	-6.35
pfcf ratio	5.46	-10.21	153.45
pb ratio	0.36	0.39	-7.05
ptb ratio	0.36	0.39	-7.05
ev to sales	0.72	0.77	-6.83
enterprise value over ebitda	5.14	7.04	-26.98
ev to operating cash flow	5.07	5.29	-4.17
ev to free cash flow	20.31	-37.14	154.70
earnings yield	0.2	0.15	33.31
free cash flow yield	0.18	-0.1	287.09
debt to equity	1.09	1.18	-7.59
debt to assets	0.32	0.33	-2.45
net debt to ebitda	3.76	5.11	-26.35
current ratio	1.0	1.0	-0.00
interest coverage	3.61	3.2	12.75
income quality	2.22	4.54	-51.08
dividend yield	0.1	0.09	12.91
payout ratio	0.5	0.59	-15.30
sales general and administrative to revenue	0.04	0.04	-4.92
research and ddevelopement to revenue	0.01	0.02	-5.08
intangibles to total assets	0	0.38	-100.00
capex to operating cash flow	0.75	1.14	-34.34
capex to revenue	0.11	0.17	-36.16
capex to depreciation	1.91	3.12	-38.95
stock based compensation to revenue	0.0	0.0	-63.70
graham number	4.7	4.09	15.07
roic	0.05	0.03	41.85
return on tangible assets	0.02	0.03	-19.34
graham net net	-2.21	-3.35	34.02
working capital	19638000	19826000	-0.95
tangible asset value	8298891000	-130259000	6471.07
net current asset value	-833142000	-1442201000	42.23
invested capital	7868974000	15542276000	-49.37
average receivables	7507305500	7556308000	-0.65
average payables	3658861500	4043971500	-9.52
average inventory	1493194500	1658910500	-9.99
days sales outstanding	239.12	252.75	-5.39
days payables outstanding	138.29	165.22	-16.30
days of inventory on hand	50.9	73.44	-30.69
receivables turnover	1.53	1.44	5.70
payables turnover	2.64	2.21	19.47
inventory turnover	7.17	4.97	44.28
roe	0.07	0.06	23.91
capex per share	0.73	1.09	-32.63

• ROE:

  Debt-to-Equity Ratio:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 4.95 on 2023-12-31 from 6.60 on 2022-12-31, representing a change of -24.99%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.00 on 2023-12-31 from 1.00 on 2022-12-31, representing a change of -0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
1899.HK
calendar year	2024	2023	NaN
revenue per share	3.29	3.64	-9.67
net income per share	0.1	0.15	-33.57
operating cash flow per share	0.2	0.19	7.00
free cash flow per share	-0.12	-0.17	28.34
cash per share	1.25	1.46	-14.00
book value per share	4.55	4.97	-8.48
tangible book value per share	4.55	5.23	-12.94
shareholders equity per share	3.39	3.66	-7.33
interest debt per share	3.87	3.97	-2.51
market cap	2286695852.65	2223738217.36	2.83
enterprise value	8457286852.65	8283766217.36	2.09
pe ratio	2.98	2.16	37.72
price to sales ratio	0.37	0.37	1.28
pocfratio	6.15	7.2	-14.50
pfcf ratio	-9.79	-7.67	-27.66
pb ratio	0.36	0.36	-1.28
ptb ratio	0.36	0.36	-1.28
ev to sales	1.37	1.36	0.55
enterprise value over ebitda	11.79	11.89	-0.84
ev to operating cash flow	22.75	26.8	-15.11
ev to free cash flow	-36.2	-28.56	-26.75
earnings yield	0.08	0.12	-27.39
free cash flow yield	-0.1	-0.13	21.67
debt to equity	1.14	1.09	5.20
debt to assets	0.33	0.32	1.77
net debt to ebitda	8.6	8.7	-1.11
current ratio	1.04	1.0	3.79
interest coverage	0	0	NaN
income quality	1.93	1.2	61.07
dividend yield	0.16	0.03	543.46
payout ratio	1.92	0.22	786.18
sales general and administrative to revenue	0.03	0.04	-12.66
research and ddevelopement to revenue	0.02	0.01	90.84
intangibles to total assets	0	-0.02	100.00
capex to operating cash flow	1.63	1.94	-15.99
capex to revenue	0.1	0.1	-0.49
capex to depreciation	1.55	2.0	-22.74
stock based compensation to revenue	0.0	-0.0	144.68
graham number	2.79	3.56	-21.54
roic	0.02	0.02	-35.81
return on tangible assets	0.01	0.01	-29.23
graham net net	-2.49	-2.33	-6.82
working capital	465735000	19638000	2271.60
tangible asset value	8536938000	8723988000	-2.14
net current asset value	-1558276000	-833142000	-87.04
invested capital	8571961000	7698428000	11.35
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	114.37	111.57	2.51
days payables outstanding	73.24	64.02	14.40
days of inventory on hand	31.76	16.6	91.33
receivables turnover	0.79	0.81	-2.45
payables turnover	1.23	1.41	-12.59
inventory turnover	2.83	5.42	-47.73
roe	0.03	0.04	-28.32
capex per share	0.32	0.36	-10.11

• Negative

  ROE: Return on Equity (ROE) decreased to 0.03 on 2024-06-30 Q2 from 0.04 on 2023-12-31 Q4, representing a change of -28.32%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 2.98 on 2024-06-30 Q2 from 2.16 on 2023-12-31 Q4, representing a change of 37.72%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.04 on 2024-06-30 Q2 from 1.00 on 2023-12-31 Q4, representing a change of 3.79%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None